ST8SIA4 and breast carcinoma: In this regard, it would be conceivable that altered expression of miR-26a/26b targeting ST8SIA4 could downregulate ST8SIA4 levels to promote breast cancer progression, whereas ST8SIA4-mutant genetic background favored the miR-26a/26b-mediated cancer progression effect.